Research on the pathogenesis of autosomal dominant polycystic kidney disease
Not Applicable
- Conditions
- Autosomal dominant polycystic kidney disease
- Registration Number
- JPRN-UMIN000019614
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 255
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who meet the following criterion if blood and/or urine samples will be collected: - Patients who, in the opinion of the investigator, are inappropriate for the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of factors that may affect the progression of ADPKD (annual percentage change in kidney volume)
- Secondary Outcome Measures
Name Time Method Evaluation of factors that may affect the progression of ADPKD (annual change in eGFR) Exploration of factors that may affect the onset of ADPKD-related events (cerebral aneurysm, hypertension, urolithiasis, renal pain, macroscopic hematuria, cyst infection, urinary tract infection, proteinuria, dialysis, and other ADPKD-related events) and other major events (e.g., cardiovascular events) Comparison of genetic background information between subjects and healthy adults